The Valley Desk

LetterBritish journal of haematologyPublished

Clinical outcomes of combination treatment with FMS-like tyrosine kinase 3 (FLT3) and isocitrate dehydrogenase 1/2 (IDH1/2) inhibitors in patients with acute myeloid leukaemia

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Letter
Venue
British journal of haematology
Published
Subject terms
Acute myeloid leukaemia; Flt3; Idh1; Idh2; Quizartinib; Midostaurin; Enasidenib; Ivosidenib; Gilteritinib
PubMed ID
42438311
PubMed Central ID
PMC13570131
Added to directory
Source checked

Report a correction or request removal